Friday, November 1, 2013

A bit more on robotic surgery to complement the post below.  Melissa Evans at Kaiser Health News notes:

The use of robotic surgical systems is expanding rapidly, but hospitals, patients and regulators may not be getting enough information to determine whether the high tech approach is worth its cost.

Problems resulting from surgery using robotic equipment—including deaths—have been reported late, inaccurately or not at all to the Food and Drug Administration, according to one study.

Dr. Martin A. Makary, an associate professor of surgery and health policy and management at John Hopkins University and one of the study’s authors,  said that, while the future for robotic surgery is promising, there is a gray area when it comes to assessing the difference between doctor and device error. And benefits from the use of the device may be inconsistent, he said.  

Makary and his co-authors noted an earlier finding that “among the 37 percent of U.S. hospitals that describe robotic surgery on their hospital website, none mentioned any potential risks or complications.

“We rely on a haphazard reporting system that uses immature data and only the best experiences make it into the data,” Makary said. “We introduce things but we don’t evaluate them very well. If we’re relying on the FDA about what (products) are superior, then we need a new process...you can’t make conclusions on the safety profile of a device based on a shoddy reporting system.”

Related Posts:

  • Thoreau says "Keep Walden Free"Well, no, he doesn't say that, but he would if he were around again.The state DCR is considering proposals that would prohibit swimmers from swimming across Walden Pond (open water swimming, or OWS).  This is raising the… Read More
  • MIT SDM Webinar: Business System IntegrationRisks and Mitigation Approaches for Business System Integration MIT SDM Systems Thinking Webinar SeriesDate: May 19, 2014Time: Noon – 1 p.m. EDTFree and open to allRegisterAbout the PresentationThe successful integratio… Read More
  • Please explain this drug pricingI don't understand this, do you?Here's a full page ad from Pfizer in the New York Times that, it seems to me, makes a prima facie case that the company is engaged in price discrimination against (1) the federal government thr… Read More
  • Thanks for the donation, doc?I guess we would call this a success, but it doesn't feel like it to me.  Indeed, it feels like someone is taking advantage of the good will of doctors.Here's the story, reported by Adam Ragesua at Marketplace.  Exc… Read More
  • Glassdoor invitationThanks to Glassdoor for inviting us to post this article. … Read More

0 comments:

Post a Comment

Blog Archive

Powered by Blogger.

Popular Posts